Zenpep Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The growth in the historic period can be attributed to increasing prevalence of cystic fibrosis, advancement of pancrelipase formulations, expansion of gastroenterology care services, improved diagnostic awareness of epi, early adoption of enzyme therapies.

The growth in the forecast period can be attributed to increasing demand for long-term digestive support therapies, rising focus on personalized dosing regimens, expansion of pediatric and adult epi treatment access, growing specialty pharmacy distribution, innovation in enzyme delivery technologies. Major trends in the forecast period include expansion of enzyme replacement therapy utilization, increasing diagnosis of exocrine pancreatic insufficiency, growing focus on digestive disorder management, enhanced formulation stability improvements, rising patient adherence programs.

The increasing prevalence of pancreatic disorders is expected to drive the growth of the Zenpep market. Pancreatic disorders, including inflammation, cancer, and enzyme imbalances, affect the pancreas’s ability to regulate blood sugar and support digestion. Factors such as rising obesity rates, unhealthy diets, high alcohol intake, smoking, and genetic predispositions contribute to the growing prevalence of these disorders. Zenpep provides pancreatic enzyme replacement therapy (PERT), supplying enzymes that break down fats, carbohydrates, and proteins. This helps patients with pancreatic insufficiency digest food properly, absorb nutrients, and alleviate symptoms such as malnutrition and digestive discomfort. For example, in August 2024, NHS England reported that cystic fibrosis, a life-limiting recessively inherited condition affecting pancreatic function, impacted around 9,259 people in England and 11,148 people across the UK. Therefore, the increasing prevalence of pancreatic disorders is propelling the Zenpep market.

The growing aging population is expected to further support Zenpep market growth. Aging populations, defined by a rising proportion of individuals aged 60 or 65 and above, face decreased production of digestive enzymes, which can lead to nutrient malabsorption. Zenpep supplements these enzymes, improving digestive health and nutrient absorption in older adults. For instance, in January 2024, the Population Reference Bureau reported that the U.S. population aged 65 and older is projected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase, with this age group’s share of the total population rising from 17% to 23%. Therefore, the expanding aging population is driving Zenpep market growth.

Increasing awareness of gastrointestinal disorders is also contributing to the growth of the Zenpep market. Gastrointestinal disorders, which affect the stomach and intestines, can cause pain, bloating, and digestive disturbances. Greater awareness is being driven by rising prevalence, improvements in diagnostic technologies, enhanced patient education, and public health initiatives focusing on digestive health. Zenpep supports the management of these disorders by providing pancreatic enzymes that aid in nutrient absorption and proper digestion. For instance, in April 2024, the ME Association reported that 10-15% of the population experiences irritable bowel syndrome, making it one of the most common gastrointestinal conditions, with 35-70% of individuals with fibromyalgia also affected. Therefore, growing awareness of gastrointestinal disorders is boosting the Zenpep market.

Major companies operating in the zenpep market are Nestle Health Science S.A.

North America was the largest region in the zenpep market in 2025. The regions covered in the zenpep market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the zenpep market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Tariffs are influencing the zenpep market by increasing costs of imported enzyme raw materials, encapsulation technologies, pharmaceutical excipients, and packaging components. North America and Europe are most affected due to dependence on specialized enzyme manufacturing inputs, while emerging markets face higher import-related pricing. These tariffs can elevate treatment costs and affect reimbursement dynamics. However, they also promote domestic pharmaceutical manufacturing, regional sourcing of excipients, and supply chain diversification for enzyme-based therapies.

The zenpep market research report is one of a series of new reports that provides zenpep market statistics, including zenpep industry global market size, regional shares, competitors with a zenpep market share, detailed zenpep market segments, market trends and opportunities, and any further data you may need to thrive in the zenpep industry. This zenpep market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Zenpep (pancrelipase) is a prescription enzyme replacement therapy used to manage exocrine pancreatic insufficiency (EPI) caused by conditions such as cystic fibrosis, chronic pancreatitis, or other pancreatic disorders. It contains digestive enzymes - lipase, protease, and amylase - that help break down fats, proteins, and carbohydrates, enhancing nutrient absorption and improving digestive function.

The main indications for Zenpep include cystic fibrosis, chronic pancreatitis, pancreatic cancer, and post-surgical pancreatic insufficiency. Cystic fibrosis is an inherited disorder that leads to thick, sticky mucus accumulation, causing respiratory and digestive problems, including insufficient pancreatic enzyme production. Zenpep is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and is used by pediatric, adult, and geriatric patients.

The zenpep market consists of sales of capsules, granules, and powder for oral solution. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.